Cibc World Markets Corp Purchases 2,181 Shares of STERIS plc (NYSE:STE)

Cibc World Markets Corp increased its stake in STERIS plc (NYSE:STE - Free Report) by 16.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,569 shares of the medical equipment provider's stock after buying an additional 2,181 shares during the period. Cibc World Markets Corp's holdings in STERIS were worth $3,200,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in STE. Geode Capital Management LLC grew its stake in shares of STERIS by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider's stock worth $556,786,000 after acquiring an additional 17,007 shares during the last quarter. Principal Financial Group Inc. increased its stake in STERIS by 0.5% during the 4th quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider's stock valued at $230,160,000 after purchasing an additional 5,419 shares in the last quarter. Raymond James Financial Inc. bought a new stake in STERIS during the 4th quarter valued at about $223,987,000. Franklin Resources Inc. raised its holdings in STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock worth $191,370,000 after buying an additional 529,308 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of STERIS by 3.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider's stock worth $117,136,000 after buying an additional 18,384 shares in the last quarter. Institutional investors own 94.69% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of brokerages recently weighed in on STE. Piper Sandler boosted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Stephens restated an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, STERIS currently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Stock Performance

Shares of NYSE STE traded down $1.44 during midday trading on Tuesday, hitting $221.57. 550,996 shares of the stock traded hands, compared to its average volume of 504,069. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The firm has a market capitalization of $21.77 billion, a P/E ratio of 47.04 and a beta of 0.92. The firm has a 50-day moving average of $221.34 and a two-hundred day moving average of $221.73.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date was Thursday, February 20th. STERIS's payout ratio is 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.